A genomic study will help to predict which patients with schizophrenia might benefit from early treatment with clozapine

by Hospital de la Santa Creu i Sant Pau

It has been bring to the table a novel genomic tool that would help to predict which patients will respond poorly to conventional treatments and, therefore, would be early candidates for treatment wit...

Read more

People with schizophrenia who participate in clinical trials may not be representative of the population suffering from this disease

by Instituto de Investigación e Innovación Parc Taulí

An international study led by I3PT notes that clinical trials may account for only about one-fifth of people in the real world with schizophrenia spectrum disorders, and points out that new studies sh...

Read more

ORYZON enrolls first patient in EVOLUTION, a Phase IIb clinical trial with vafidemstat in schizophrenia

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...

Read more

ORYZON receives approval to start EVOLUTION Phase IIb trial with vafidemstat in schizophrenia

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...

Read more

ORYZON Launches Pioneering Schizophrenia Precision Medicine Study In Collaboration With Columbia Psychiatry

by Oryzon Genomics

Goal is to characterize the neuropsychiatric symptoms of patients harboring disease-causing SETD1A gene mutations Also includes fundamental research in preclinical SETD1A models

Read more

The lack of interaction between two neuronal receptors is a determining factor in schizophrenia

by Universitat de Barcelona

Schizophrenia is a severe neuropsychiatric disorder which is presented through hallucinations, delusions and behavioural and motor disorders. Historically, this disease was associated with an overacti...

Read more

ORYZON initiates a new project to explore the efficacy of vafidemstat in the treatment of schizophrenia

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...

Read more

Significant differences exist among neurons expressing dopamine receptors

by Universitat Autònoma de Barcelona (UAB)

An international collaboration, which included the involvement of the research team from the Institut de Neurociències (INC) and from the Department of Cellular Biology, Physiology and Immunology, ha...

Read more

Experts in G protein-coupled receptors meet at the UB to discuss new pharmacological perspectives

by Hospital Universitari de Bellvitge

Within the framework of the X Esteve Foundation Discussion Group, on February 13th and 14th the tenth meeting of the working group on new advances in the field of G-protein coupled receptors (GPCR) wa...

Read more

Biological diagnosis of schizophrenia: the future

by Fundació Clínic per a la Recerca Biomèdica

Schizophrenia is a very heterogeneous disease, patients who suffer this may present a variety of symptoms. In addition, there is currently no analytical or imaging test that confirms the diagnosis. Th...

Read more

Advances in the study of drugs to combat cognitive impairment in schizophrenia

by Universidad del País Vasco

The UPV/EHU-University of the Basque Country is proposing improvements with respect to the pharmacological study of cognitive function enhancers in patients with schizophrenia

Read more

Describen alteraciones en estructuras cerebrales en pacientes con esquizofrenia descubiertas mediante un innovador análisis de imagen cerebral

by Cibersam- Centro de Investigación Biomédica en Red de Salud Mental

Para intentar clarificar el tipo de anomalías estructurales cerebrales presentes en la esquizofrenia, se ha llevado a cabo un innovador meta-análisis prospectivo que analiza datos de imagen cerebral...

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New strategy to facilitate muscle regen...

by Universitat de Barcelona

This is the first study to provide scientific evidence for faster and ...

Photos Stream